statistiche ricercatore

Continente	#
AS - Asia	592
NA - Nord America	525
EU - Europa	361
Continente sconosciuto - Info sul continente non disponibili	45
SA - Sud America	26
AF - Africa	24
Totale	1.573

Nazione	#
US - Stati Uniti d'America	479
IT - Italia	187
VN - Vietnam	168
SG - Singapore	141
CN - Cina	101
HK - Hong Kong	65
NL - Olanda	40
BD - Bangladesh	37
SE - Svezia	22
CA - Canada	19
IE - Irlanda	19
FR - Francia	17
KR - Corea	17
BR - Brasile	16
DE - Germania	14
AT - Austria	13
GB - Regno Unito	12
IN - India	11
CH - Svizzera	10
JP - Giappone	9
PH - Filippine	8
TH - Thailandia	8
ZA - Sudafrica	8
ID - Indonesia	7
MX - Messico	7
FI - Finlandia	6
HN - Honduras	5
PK - Pakistan	5
TG - Togo	5
TR - Turchia	5
CI - Costa d'Avorio	4
RU - Federazione Russa	4
TW - Taiwan	4
CR - Costa Rica	3
IQ - Iraq	3
PL - Polonia	3
VE - Venezuela	3
BE - Belgio	2
CL - Cile	2
EC - Ecuador	2
JM - Giamaica	2
NG - Nigeria	2
NI - Nicaragua	2
PT - Portogallo	2
UA - Ucraina	2
AL - Albania	1
AR - Argentina	1
BB - Barbados	1
BG - Bulgaria	1
CM - Camerun	1
CO - Colombia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
ET - Etiopia	1
GD - Grenada	1
HT - Haiti	1
IL - Israele	1
IS - Islanda	1
LT - Lituania	1
LU - Lussemburgo	1
MQ - Martinica	1
MY - Malesia	1
PR - Porto Rico	1
PY - Paraguay	1
SC - Seychelles	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TT - Trinidad e Tobago	1
Totale	1.528

Nome	#
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs	262
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma	256
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis	176
Outcome of hepatic resection for HCC in ideal and non-ideal candidates	173
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab	123
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	116
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study	113
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care	106
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma	100
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab	68
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review	45
Primary biliary cholangitis: current insights and novel therapies	35
Totale	1.573

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	0	0	0	0	10	1	7	21	3
2022/2023	66	2	7	2	2	7	3	16	2	10	1	7	7
2023/2024	35	1	3	1	3	3	4	2	11	2	2	0	3
2024/2025	170	7	10	13	9	7	9	27	6	7	33	16	26
2025/2026	1.009	58	42	58	62	71	36	158	66	233	100	44	81
2026/2027	251	59	62	81	49	0	0	0	0	0	0	0	0
Totale													1.573

CRIS Current Research Information System